Tag: 21 CFR Part 11

Data Flow Mapping to Identify Integrity Risks Across the Study Ecosystem

Posted on By digi

Data Flow Mapping to Identify Integrity Risks Across the Study Ecosystem Data Flow Mapping to Identify Integrity Risks Across the Study Ecosystem Data integrity in clinical trials is critical to ensuring the validity and reliability of trial results. With increasing regulatory scrutiny and the imperative to maintain compliance with established standards such as ALCOA++ and…

Read More “Data Flow Mapping to Identify Integrity Risks Across the Study Ecosystem” »

Data Integrity (ALCOA++, 21 CFR Part 11)

Handling Corrections, Late Entries and Data Changes in GCP Systems

Posted on By digi

Handling Corrections, Late Entries and Data Changes in GCP Systems Handling Corrections, Late Entries and Data Changes in GCP Systems The integrity of data in clinical trials is paramount for regulatory compliance, particularly under the guidelines of ICH-GCP, 21 CFR Part 11, and various other regulations established by authorities such as FDA, EMA, and MHRA….

Read More “Handling Corrections, Late Entries and Data Changes in GCP Systems” »

Data Integrity (ALCOA++, 21 CFR Part 11)

Designing Systems and Processes That Embed ALCOA++ Principles

Posted on By digi

Designing Systems and Processes That Embed ALCOA++ Principles In an era where data integrity is paramount in clinical research, the principles of ALCOA++ are essential in ensuring the quality and reliability of clinical trial data. This step-by-step guide will provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU with…

Read More “Designing Systems and Processes That Embed ALCOA++ Principles” »

Data Integrity (ALCOA++, 21 CFR Part 11)

Part 11 Requirements for Electronic Records, Signatures and Audit Trails

Posted on By digi

Part 11 Requirements for Electronic Records, Signatures and Audit Trails Understanding Part 11 Requirements for Electronic Records, Signatures and Audit Trails The advent of electronic records in clinical trials has revolutionized data management. However, it also introduces regulatory challenges that professionals must navigate to ensure compliance with international standards. This guide will provide a comprehensive…

Read More “Part 11 Requirements for Electronic Records, Signatures and Audit Trails” »

Data Integrity (ALCOA++, 21 CFR Part 11)

Data Integrity in Clinical Trials: Applying ALCOA++ and 21 CFR Part 11

Posted on By digi

Data Integrity in Clinical Trials: Applying ALCOA++ and 21 CFR Part 11 Data integrity is paramount in clinical trials, underpinning the reliability of results and the safety of patients. This article will provide a comprehensive step-by-step guide for clinical research professionals to understand and implement the principles of ALCOA++ and the regulatory requirements of 21…

Read More “Data Integrity in Clinical Trials: Applying ALCOA++ and 21 CFR Part 11” »

Data Integrity (ALCOA++, 21 CFR Part 11)

Audit Trails & Forensic Readiness: Engineering Evidence That Survives Regulatory Scrutiny

Posted on By digi

Audit Trails & Forensic Readiness: Engineering Evidence That Survives Regulatory Scrutiny Audit Trail Mastery and Forensic Readiness for Global GCP Inspections First Principles: What Regulators Expect from Audit Trails—and Why Audit trails are the verifiable footprints that show who did what, when, where, and why—across every system that touches clinical data and decisions. They underpin…

Read More “Audit Trails & Forensic Readiness: Engineering Evidence That Survives Regulatory Scrutiny” »

Audit Trails & Forensic Readiness, Clinical Audits, Inspections & Readiness

Mock Audits & Readiness Rooms: Rehearsals, Playbooks, and Evidence Control for Seamless Inspections

Posted on By digi

Mock Audits & Readiness Rooms: Rehearsals, Playbooks, and Evidence Control for Seamless Inspections Turning Practice into Performance: How to Run Mock Audits and Build Readiness Rooms that Impress Inspectors Why Rehearsals Matter: The Business Case and Scope Mock audits are structured rehearsals that expose gaps before regulators do. They compress months of process into hours…

Read More “Mock Audits & Readiness Rooms: Rehearsals, Playbooks, and Evidence Control for Seamless Inspections” »

Clinical Audits, Inspections & Readiness, Mock Audits & Readiness Rooms

Validation & Part 11 Compliance: Risk-Based Assurance for eClinical Systems (2025)

Posted on By digi

Validation & Part 11 Compliance: Risk-Based Assurance for eClinical Systems (2025) Engineering Validation and Part 11 Compliance That Withstand Inspection Purpose, Scope, and the Global Compliance Frame for Digital Records Validation and Part 11 compliance are the foundation of trustworthy electronic records and signatures in clinical development. The objective is to demonstrate—proportionate to risk—that every…

Read More “Validation & Part 11 Compliance: Risk-Based Assurance for eClinical Systems (2025)” »

eClinical Technologies & Digital Transformation, Validation & Part 11 Compliance

Data Management, EDC Systems, and Data Integrity — The Backbone of Reliable Clinical Research

Posted on By digi

Data Management, EDC Systems, and Data Integrity — The Backbone of Reliable Clinical Research Data Management, EDC Systems, and Integrity: The Backbone of Trustworthy Clinical Research Clinical data is the cornerstone of every regulatory submission, and its credibility determines whether a new therapy reaches the market. For professionals managing trials in the U.S., U.K., and…

Read More “Data Management, EDC Systems, and Data Integrity — The Backbone of Reliable Clinical Research” »

Data Management, EDC & Data Integrity